Get the Stockscreener App
56.14
2.31%
1.27
Tempus Ai Inc stock is traded at $56.14, with a volume of 8.95M.
It is up +2.31% in the last 24 hours and up +20.32% over the past month.
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
See More
Previous Close:
$54.87
Open:
$54.215
24h Volume:
8.95M
Relative Volume:
1.43
Market Cap:
$10.08B
Revenue:
$1.36B
Net Income/Loss:
$-302.91M
P/E Ratio:
-32.67
EPS:
-1.7182
Net Cash Flow:
$-219.93M
1W Performance:
+10.42%
1M Performance:
+20.32%
6M Performance:
-10.46%
1Y Performance:
-17.85%
1-Day Range:
$53.37
$57.10
1-Week Range:
$46.68
$57.10
52-Week Range:
$41.73
$104.32
Tempus Ai Inc Stock (TEM) Company Profile
Name
Tempus Ai Inc
Sector
Industry
Phone
800-976-5448
Address
600 WEST CHICAGO AVENUE, CHICAGO
Compare TEM vs VEEV, BTSG, HQY, HNGE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
56.14 | 10.08B | 1.36B | -302.91M | -219.93M | -1.7182 |
VEEV
Veeva Systems Inc
|
171.36 | 27.84B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
68.98 | 13.54B | 13.65B | 169.86M | 412.12M | 1.0758 |
HQY
Healthequity Inc
|
88.46 | 7.40B | 1.34B | 230.70M | 440.96M | 2.6695 |
HNGE
Hinge Health Inc
|
78.97 | 6.11B | 646.34M | -512.40M | 202.76M | -6.6871 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-13-26 | Initiated | Jefferies | Underperform |
| Apr-13-26 | Upgrade | TD Cowen | Hold → Buy |
| Feb-19-26 | Initiated | Mizuho | Outperform |
| Feb-17-26 | Initiated | Robert W. Baird | Outperform |
| Dec-02-25 | Resumed | Morgan Stanley | Overweight |
| Oct-21-25 | Downgrade | TD Cowen | Buy → Hold |
| Oct-20-25 | Initiated | Canaccord Genuity | Buy |
| Sep-02-25 | Initiated | H.C. Wainwright | Buy |
| Apr-21-25 | Initiated | BTIG Research | Buy |
| Feb-25-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-12-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Feb-05-25 | Resumed | TD Cowen | Buy |
| Dec-13-24 | Initiated | Wolfe Research | Outperform |
| Dec-09-24 | Initiated | Guggenheim | Buy |
| Nov-11-24 | Downgrade | Stifel | Buy → Hold |
| Oct-02-24 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-12-24 | Initiated | Piper Sandler | Neutral |
| Jul-09-24 | Initiated | BofA Securities | Buy |
| Jul-09-24 | Initiated | JP Morgan | Overweight |
| Jul-09-24 | Initiated | Longbow | Buy |
| Jul-09-24 | Initiated | Loop Capital | Buy |
| Jul-09-24 | Initiated | Morgan Stanley | Overweight |
| Jul-09-24 | Initiated | Needham | Buy |
| Jul-09-24 | Initiated | Stifel | Buy |
| Jul-09-24 | Initiated | TD Cowen | Buy |
| Jul-09-24 | Initiated | William Blair | Outperform |
View All
Tempus Ai Inc Stock (TEM) Latest News
Tempus AI (TEM) is Amongst AI stocks Under $30 That Carry High Short Interest - Yahoo Finance
Tempus AI (TEM) Expands Rare Cancer Research, Is The Stock Fully Priced? - simplywall.st
5 Worst Artificial Intelligence Stocks Under $30 According to Short Sellers - Insider Monkey
Tempus AI Stock (TEM) Opinions on Healthcare AI Breakthroughs - Quiver Quantitative
Tempus AI Stock Short Interest Rises to 38.44% - Quiver Quantitative
Tempus AI, Inc. $TEM Shares Sold by SG Americas Securities LLC - MarketBeat
Tempus AI stock jumps on rare cancer research partnership - Investing.com
Why is Tempus AI stock rallying today? - Investing.com UK
TEM (NASDAQ: TEM) insider resale: 11,529 RSU shares listed for sale - Stock Titan
Investors Purchase High Volume of Call Options on Tempus AI (NASDAQ:TEM) - MarketBeat
Tempus AI, Inc. Class A Actuals & Estimates (NASDAQ:TEM) - TradingView
Tempus AI partners with Angiosarcoma Awareness on rare cancer research By Investing.com - Investing.com South Africa
Why is Tempus AI stock rallying today? By Investing.com - Investing.com South Africa
Tempus AI stock jumps on rare cancer research partnership By Investing.com - Investing.com Nigeria
Tempus AI partners with Angiosarcoma Awareness on rare cancer research - Investing.com
Tempus Announces Research Collaboration with Angiosarcoma Awareness, Inc. to Uncover Insights on Rare Cancers - marketscreener.com
TEM Forecast — Price Target — Prediction for 2027 - TradingView
Price to sales forward of Tempus AI, Inc. – NASDAQ:TEM - TradingView
Price to earnings forward of Tempus AI, Inc. – NASDAQ:TEM - TradingView
The pink kinda moving average line is a little problem, the red dashed is certainly a take profit and wait line - Moomoo
Is Tempus AI, Inc. (TEM) Among the Best AI Drug Discovery Stocks to Buy According to Hedge Funds? - Insider Monkey
Redditors Think Tempus AI (TEM) Still Has 10X Potential - Yahoo Finance
10 Stocks That Will 10X According to Social Media - Insider Monkey
12 Best AI Drug Discovery Stocks Hedge Funds Are Loading Up On - Insider Monkey
Tempus AI Tumbles as Lock-Up Expiry Spooks Investors - TipRanks
Chicago has a new highest-paid CEO - Crain's Chicago Business
Tempus AI, Inc. (TEM) Stock Analysis: Unpacking The 30.87% Upside Potential For Investors - DirectorsTalk Interviews
Can Tempus AI’s (TEM) New ECG-AF Validation Deepen Its Edge in Clinical-Grade Healthcare AI? - simplywall.st
Caitong International Asset Management Co. Ltd Acquires 27,022 Shares of Tempus AI, Inc. $TEM - MarketBeat
Tempus finance chief joins Needham healthcare event on April 14 - Stock Titan
Tempus AI, Inc. $TEM Shares Acquired by Virtu Financial LLC - MarketBeat
Tempus AI Inc (TEM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Should You Retain Tempus AI Stock In Your Portfolio Now? - TradingView
Tempus AI Stock (TEM) Opinions on Market Momentum - Quiver Quantitative
Tempus AI Inc (TEM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Tempus AI Inc (TEM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Nano Dimension and Infinite Epigenetics Provide Additional Information Regarding Proposed Business Combination - GlobeNewswire Inc.
Tempus AI (TEM) Price Forecast: Consolidation Bottom Breakout Looms - FXEmpire
Tempus Al, Inc. (TEM) Opens Open-Source Digital Pathology Consortium - Insider Monkey
TEM Stock Quote Price and Forecast - CNN
Tempus AI, Inc. (TEM) Stock Analysis: Navigating a 39% Potential Upside Amidst Cutting-Edge Healthcare Innovations - DirectorsTalk Interviews
Entropy Technologies LP Purchases New Holdings in Tempus AI, Inc. $TEM - MarketBeat
Tempus AI (TEM) Stock After 23% Year-To-Date Decline Is Opportunity Emerging - Yahoo Finance
Tempus AI Inc. (TEM) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
TEM News | TEMPUS AI INC-CL A (NASDAQ:TEM) - ChartMill
Tangible book value per share of Tempus AI, Inc. Shs A Cert Deposito Arg Repr 0.08333333 Sh A – BCBA:TEM.CI - TradingView
Revenue per share of Tempus AI, Inc. Shs A Cert Deposito Arg Repr 0.08333333 Sh A – BCBA:TEM.CI - TradingView
Debt to assets ratio of Tempus AI, Inc. Shs A Cert Deposito Arg Repr 0.08333333 Sh A – BCBA:TEM.CI - TradingView
Kelli Teno-Manalli Joins Tempus AI as Vice President, Head of Communications - hrtoday.in
Tempus AI Stock (TEM) Opinions on Earnings Guidance and Acquisition Speculation - Quiver Quantitative
Tempus AI: AI Precision Medicine With A Moat (NASDAQ:TEM) - Seeking Alpha
Tempus Ai Inc Stock (TEM) Financials Data
Revenue
Net Income
Cash Flow
EPS
6.03%
1.03%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):